XML 42 R27.htm IDEA: XBRL DOCUMENT v3.25.1
Commitments and Contingencies (Tables)
12 Months Ended
Dec. 30, 2024
Commitments and Contingencies  
Schedule Of Future Minimum Lease Payments Under Financing Leases

For the Year Ending December 31, 2024

 

Amount

 

 

 

$

 

2025

 

 

55,672

 

2026

 

 

55,672

 

2027

 

 

55,672

 

2028

 

 

55,672

 

2029

 

 

55,671

 

Greater than 5 years

 

 

132,204

 

Total

 

 

410,563

 

Less: Amount representing interest

 

 

(35,488)

Total Finance Lease Liabilities

 

 

375,075

 

Schedule Of Operating Lease Right-of-Use Liabilities

 

 

 December 31, 2024

 

 

 December 31, 2023

 

 

 

$

 

 

$

 

Operating right-of-use assets

 

 

599,816

 

 

 

549,504

 

 

 

 

 

 

 

 

 

 

Operating lease liabilities, current portion

 

 

221,755

 

 

 

199,323

 

Operating lease liabilities, long term

 

 

410,686

 

 

 

378,054

 

Total operating lease liabilities

 

 

632,441

 

 

 

577,377

 

 

 

 

 

 

 

 

 

 

Weighted average remaining lease (months)

 

 

48

 

 

 

25

 

Weighted average discount rate

 

 

3.70%

 

 

2.38%

 

Schedule Of Future Minimum Lease Payments Under Operating Leases

For the Year Ending December 31, 2024

 

Amount

 

 

 

$

 

2025

 

 

244,273

 

2026

 

 

229,108

 

2027

 

 

148,590

 

2028

 

 

54,343

 

2029

 

 

-

 

Total

 

 

676,314

 

Less: imputed interest

 

 

(43,873)

Total Operating Lease Liabilities

 

 

632,441

 

 

Schedule Of Recognized In Short-term Lease Costs

For the Year Ending December 31, 2024

 

Amount

 

 

 

$

 

2025

 

 

11,874

 

Total Operating Lease Liabilities

 

 

11,874

 

 

Schedule Of Grants Repayable

For the Year Ending December 31, 2024

 

Amount

 

 

 

$

 

2025

 

 

60,978

 

2026

 

 

42,305

 

2027

 

 

46,968

 

2028

 

 

50,228

 

2029

 

 

51,629

 

Greater than 5 years

 

 

170,113

 

Total Grants Repayable

 

 

422,221

 

Schedule Of Long-term Debt Payable

For the Year Ending December 31, 2024

 

Amount

 

 

 

$

 

2025

 

 

1,263,036

 

2026

 

 

978,784

 

2027

 

 

787,099

 

2028

 

 

2,523,491

 

2029

 

 

127,296

 

Greater than 5 years

 

 

176,311

 

Total

 

 

5,856,017

 

Less: amount representing interest

 

 

(1,042,948)

Total Long-Term Debt

 

 

4,813,069

 

Schedule of annual payments Of Collaborative Agreement Obligations

 

 

Total Amount Remaining

 

 

2025

 

 

 

$

 

 

 $

 

National University of Taiwan

 

 

510,000

 

 

 

510,000

 

MD Anderson Cancer Center

 

 

277,092

 

 

 

277,092

 

Guys and St Thomas

 

 

162,609

 

 

 

162,609

 

Xenetic Biosciences

 

 

81,447

 

 

 

81,447

 

University Medical Centre Amsterdam

 

 

89,370

 

 

 

89,370

 

Total Collaborative Obligations 

 

 

1,120,518

 

 

 

1,120,518

 

Schedule of outcomes related to the prescribed performance targets

Total  Award $

 

 

Vesting  Year

 

Amortized 2024 $

 

 

Amortized 2023 $

 

 

Amortized 2022 $

 

 

Un-Amortized $

 

 

527,940

 

 

2023

 

 

-

 

 

 

393,853

 

 

 

134,087

 

 

 

-

 

 

516,040

 

 

2024

 

 

190,833

 

 

 

260,119

 

 

 

65,088

 

 

 

-

 

 

510,931

 

 

2025

 

 

171,519

 

 

 

177,584

 

 

 

46,686

 

 

 

115,142

 

 

1,554,911

 

 

 

 

 

362,352

 

 

 

831,556

 

 

 

245,861

 

 

 

115,142

 

Schedule of commitments in respect of corporate goals and performance based awards

Total  Award $

 

 

Vesting  Year

 

Amortized 2024 $

 

 

Amortized 2023 $

 

 

Un-Amortized $

 

 

242,902

 

 

2024

 

 

148,132

 

 

 

94,770

 

 

 

-

 

 

231,266

 

 

2025

 

 

103,578

 

 

 

47,513

 

 

 

80,175

 

 

226,374

 

 

2026

 

 

69,116

 

 

 

31,703

 

 

 

125,555

 

 

700,542

 

 

 

 

 

320,826

 

 

 

173,986

 

 

 

205,730